Advertisement
Timing and type of side effects differ greatly from chemotherapy
Collaboration was key to identifying source of nerve condition
A review of expanding options that hold new promise
Patient able to avoid surgery and radiation despite having rapidly growing mass
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Can T-cell immunophenotyping help inform treatment decisions?
Intracranial injection of supercharged immune cells proceeds to phase 2 testing
Immune toxicity remains a diagnosis of exclusion, and multidisciplinary collaboration remains the cornerstone for early diagnosis and treatment.
Pathogenic POLE/POLD1 mutations lead to improved response to immune checkpoint blockade therapy
Study to test efficacy of immunotherapy with chemotherapy and radiation
In search of improved outcomes for patients
Advertisement
Advertisement